Synonyms: | Guanidine,[[3-(5-nitro-2-furyl)-1-[2-(5-nitro-2-furyl)vinyl]allylidene]amino]-(6CI,7CI,8CI); Hydrazinecarboximidamide,2-[3-(5-nitro-2-furanyl)-1-[2-(5-nitro-2-furanyl)ethenyl]-2-propenylidene]-(9CI); 1,4-Pentadien-3-one, 1,5-bis(5-nitro-2-furanyl)-,(aminoiminomethyl)hydrazone; 1,5-Bis(5-nitro-2-furyl)-3-pentadienoneamidinohydrazone; Biovin 40; Bis(5-nitro-2-furfurylidene)acetoneguanylhydrazone; Bis(5-nitrofurfurylidine)acetone guanylhydrazone; Difurazone;Nitrovin |
InChI: | InChI=1/C14H14N6O6/c15-14(16)18-17-9(8-11-5-7-13(26-11)20(23)24)2-1-3-10-4-6-12(25-10)19(21)22/h1,3-7H,2,8H2,(H4,15,16,18) |
Report: |
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 117.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 31 ,1983,p. 185.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
|